Lilly says antibody reduces need for hospitalization for moderate Covid-19 patients
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
TUESDAY, MAY 17, 2022
TUESDAY, MAY 17, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Lilly says antibody reduces need for hospitalization for moderate Covid-19 patients

Coronavirus chronicle

Reuters
16 September, 2020, 04:55 pm
Last modified: 16 September, 2020, 05:00 pm

Related News

  • US FDA authorizes Eli Lilly's Covid-19 antibody drug
  • Covid Science: Virus leaves antibodies that may attack healthy tissues
  • Lilly withdraws from EU rolling review of Covid-19 antibodies
  • US study suggests breast milk of vaccinated mothers contain antibodies
  • Indian study finds big drop in Covid antibodies within four months of vaccination

Lilly says antibody reduces need for hospitalization for moderate Covid-19 patients

Lilly said it expects to publish the results of the interim analysis in a peer-reviewed journal and discuss appropriate next steps with global regulators

Reuters
16 September, 2020, 04:55 pm
Last modified: 16 September, 2020, 05:00 pm
FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, US, May 18, 2018. REUTERS/Brendan McDermid
FILE PHOTO: The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, US, May 18, 2018. REUTERS/Brendan McDermid

Eli Lilly & Co said on Wednesday that its experimental antibody reduced the need for hospitalization and emergency room visits for patients with moderate Covid-19, according to an interim analysis of a mid-stage clinical trial.

The study tested three different doses of LY-CoV555, a manufactured antibody designed to recognize and lock onto the novel coronavirus, preventing the infection from spreading.

Of the total 302 patients treated with three different doses of LY-CoV555, five of them, or 1.7 percent, had to be admitted to a hospital or visit a hospital emergency room. That compares with a rate of 6 percent, or 9 out of 150, for trial patients given a placebo, the company said.

Only the middle dose, 2,800 milligrams, achieved the trial's main goal of reducing the amount of virus detected in patients compared to a placebo 11 days after treatment, it added.

No drug-related serious adverse events were reported and there have been no trial deaths.

Lilly said it expects to publish the results of the interim analysis in a peer-reviewed journal and discuss appropriate next steps with global regulators.

The company said most hospitalizations occurred in patients with underlying risk factors such as being elderly or obese, suggesting a more pronounced treatment effect for people in these higher-risk groups.

"The results reinforce our conviction that neutralizing antibodies can help in the fight against Covid-19," Daniel Skovronsky, Lilly's chief scientific officer, said in a statement.

The company said the trial was ongoing and has now enrolled 800 patients with mild-to-moderate Covid-19. The trial is also studying LY-CoV555 in combination with a second Lilly antibody, LY-CoV016, which binds a different area of the coronavirus' spike protein.

The antibodies, which are given by intravenous infusion, are also being tested for preventing Covid-19 in residents and staff at long-term care facilities and for treating patients already hospitalized due to Covid-19.

Eli Lilly / Covid-19 Antibody

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    How Putin revived Nato
  • Are banks only gainers from dollar crisis?
    Are banks only gainers from dollar crisis?
  • Urban areas are already emerging as the new poverty frontier. Photo: Mumit M/TBS
    TCB truck sales apparently draw to a close

MOST VIEWED

  • Two women hug at a closed street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 16, 2022. REUTERS/Aly Song
    Shanghai achieves 'zero Covid' status but normal life is weeks away
  • People wearing protective face masks commute amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea March 30, 2020, in this photo released by Kyodo. Picture taken March 30, 2020. Mandatory credit Kyodo/via REUTERS
    N Korea mobilises army, steps up tracing amid Covid wave
  • Customers wait in front of a restaurant in Beijing, China April 15, 2022. REUTERS/Tingshu Wang/Files
    China's economy skids as lockdowns hit factories, retailers
  • A medical worker in a protective suit collects a swab from a resident at a makeshift nucleic acid testing site inside a residential compound under lockdown, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China April 14, 2022. REUTERS/Xihao Jiang
    Shanghai aims for return to normal life from 1 June
  • South Korea's new President Yoon Suk-yeol signs a document as he works at the new Presidential office in Seoul, South Korea, May 10, 2022. Yonhap via REUTERS/File Photo
    S Korea says it will spare no effort to help North Korea amid Covid outbreak
  • North Korean leader Kim Jong Un wears a face mask amid the coronavirus disease (Covid-19) outbreak, while inspecting a pharmacy in Pyongyang, in this undated photo released by North Korea's Korean Central News Agency (KCNA) on May 15, 2022. KCNA via REUTERS
    Kim Jong Un orders North Korea military to 'stabilise' drug supply amid Covid outbreak

Related News

  • US FDA authorizes Eli Lilly's Covid-19 antibody drug
  • Covid Science: Virus leaves antibodies that may attack healthy tissues
  • Lilly withdraws from EU rolling review of Covid-19 antibodies
  • US study suggests breast milk of vaccinated mothers contain antibodies
  • Indian study finds big drop in Covid antibodies within four months of vaccination

Features

Despite Bangladesh having about 24,000 km of waterways, only a few hundred kilometres are covered by commercial launch services. Photo: Saad Abdullah

Utilising waterways: When common home-goers show the way

28m | Panorama
Illustration: TBS

How Putin revived Nato

2h | Panorama
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam

The United House: Living and working inside nature

2h | Habitat
Pcycle team members at a waste management orientation event. Photo: Courtesy

Pcycle: Turning waste from bins into beautiful crafts

3h | Panorama

More Videos from TBS

Can your coworker be your closest friend?

Can your coworker be your closest friend?

3h | Videos
The mystery behind Pyramid

The mystery behind Pyramid

3h | Videos
Finland, Sweden decide to join NATO

Finland, Sweden decide to join NATO

15h | Videos
Where you can swim for Tk5

Where you can swim for Tk5

17h | Videos

Most Read

1
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

2
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

3
Impact of falling taka against US dollar
Banking

Taka losing more value as global currency market volatility persists

4
Govt tightens belt to relieve reserve
Economy

Govt tightens belt to relieve reserve

5
Union Capital asked to return Tk100cr FDR to BATBC 
Banking

Union Capital asked to return Tk100cr FDR to BATBC 

6
How Bangladesh can achieve edible oil self-sufficiency with local alternatives
Bazaar

How Bangladesh can achieve edible oil self-sufficiency with local alternatives

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab